A multiomic analysis led by the IrsiCaixa AIDS Research Institute has uncovered genetic and immune mechanisms in some ...

Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...

PrEP use increased between 2013 and 2023, according to a research letter published online in the Journal of the American Medical Association.

Long-acting injectable PrEP is now to be covered without cost-sharing under Affordable Care Act rules, the Biden ...

With just 15 days until the presidential election, the federal government is proposing new rules that aim to bolster ...

The measure waives the need for a primary care physician’s prescription for HIV medications like PrEP and Doxy PEP.

Viatris, a manufacturer of generic antiretroviral HIV drugs and hormonal contraceptives ... promising preclinical and clinical results for on-demand topical pre- or post-exposure HIV prevention.

The data from 31 presentations across HIV treatment and prevention ... data will include an analysis of newly initiated pre-exposure prophylaxis (PrEP) use in priority populations with unmet ...

A health worker takes blood samples of people who want to undertake voluntary HIV testing at the University of the Philippines Manila. Jonathan Cellona, ABS-CBN News/FileMANILA — The Philippines ...

Chaphalkar, PhD.New research reveals that doxycycline post-exposure prophylaxis raises resistance gene levels in the gut, but ...

If you ever test positive for HIV, you will need to start treatment for HIV. Because Apretude is a long-acting injection, it can remain in your body for up to 12 months or longer after the last dose.